Blood Screening Market CAGR is expected to be 8.2% during the forecast period and the market size is expected to reach nearly US$ 4.69 Bn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology :- Request Free Sample Report A blood screening is a medical process in which a sample of blood is withdrawn from the body to analyze the level of substances or cells. It helps to monitor diseases and prevent health issues and a variety of other conditions such as infections and cancer. Human immunodeficiency virus (HIV), blood type, and pregnancy screenings are the most common types of blood screening tests done in the blood screening. Blood donor screening is the defense mechanism implemented against the spread of infection prior to the blood donation. Increase in prevalence of infectious diseases, increase in awareness about healthcare, the rise in a number of blood donations, and a surge in adoption of nucleic acid amplification test (NAT) would create more opportunities for the overall market growth and drive the market positively. However, the threat from substitute techniques, low donation as compared to requirement and the high cost of kits or other instruments are the factors that may restrain the market growth of blood screening.
Blood Screening Market Segment Analysis:Blood Screening Market is segmented by technology, product, and service, end-user and region. Among technology, nucleic acid test (NAT) and enzyme-linked immunosorbent assay (ELISA)accounted for the xx% share in 2022, nucleic acid test (NAT) are projected to progress at xx% growth rate in the future due to high sensitivity and specificity for viral nucleic acid. Based on products and service, reagents & kits and enzymes and polymerases products are accounted to hold xx% shares in the forecast period of 2023-2029. Reagents& kits product are projected to develop at the xx% growth rate in the coming future due to the rise in blood donations, an increase in the incidence of infectious diseases, and government initiatives.
Blood Screening Market Regional Analysis:Among regions, North America is expected to grow at the xx% CAGR during the forecast period due to the growing adoption of nucleic acid tests (NAT) and increasing participation of various government associations in blood donations and screening & transfusion activities. The APAC is expected to grow at the xx% CAGR during the forecast period because of the high adoption rate of technologically advanced devices and presence of improving healthcare infrastructure. Amongst the key players, Abbott labs have visible sturdy sales boom within the recent past, primarily reflecting the effect of acquisitions it made during the last couple of years. Abbott sighted new development in its medical devices and generic pharmaceuticals business. It is expected that this trend will continue in the near future as well. In 2022, Abbott’s Diagnostics business saw a sharp rise in revenues to around $7 billion mainly due to the influence of the Alere acquisition. The objective of the report is to present comprehensive analysis of Blood Screening market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Blood Screening market dynamics, structure by analyzing the market segments, and project the Blood Screening market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Blood Screening market make the report investor’s guide.
Blood Screening Market, Key Highlights:Blood Screening Market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Blood Screening Market Blood Screening Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Blood Screening Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Blood Screening Market are also profiled.
Blood Screening Market Report Scope: Inquire before buying
Blood Screening Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.70Bn. Forecast Period 2023 to 2029 CAGR: 8.2% Market Size in 2029: US $ 4.69 Bn. Segments Covered: by Technology Nucleic Acid Test (NAT) Transcription-mediated Amplification (TMA) Real-time Polymerase Chain Reaction (PCR) Enzyme-linked Immunosorbent Assay (ELISA) By Platform Chemiluminescence Immunoassay (CLIA) Fluorescence Immunoassay (FIA) Colorimetric Immunoassay (CI) By Generation First Generation Second Generation Third Generation Fourth Generation & Above Rapid Tests Western Blot Assay Next-generation Sequencing (NGS) by Product & Service Reagents & Kits NAT Reagents & Kits Enzymes and Polymerases Standards and Controls Probes and Primers Buffers, Nucleotides, and Solutions Labeling and Detection Reagents ELISA Reagents & Kits Immunosorbents Controls Conjugates Substrates Sample Diluents and Wash Solutions Other Reagents & Kits Instruments Rental Purchase Outright Purchase Software and Services by End User Blood Banks Hospitals
Blood Screening Market by RegionNorth America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America
Blood Screening Market Key Players:1. Abbott Laboratories 2. Grifols 3. Roche Diagnostics 4. Thermo Fisher Scientific, Inc. 5. bioMérieux 6. Bio-Rad Laboratories, Inc. 7. Siemens Healthineers 8. Ortho Clinical Diagnostics, Inc. 9. Becton, Dickinson, and Company 10. Beckman Coulter, Inc. 11. Becton Dickinson and Company 12. Grifols 13. Danaher Corporation (Beckman Coulter) 14. F. Hoffmann-La Roche Ltd. 15. Enzo Biochem Inc. 16. Meridian Bioscience, Inc. 17. BD 18. Cepheid 19. Immucor, Inc. 20. Hologic Inc Frequently Asked Questions: 1. Which region has the largest share in Global Blood Screening Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Blood Screening Market? Ans: The Global Blood Screening Market is growing at a CAGR of 8.2% during forecasting period 2023-2029. 3. What is scope of the Global Blood Screening market report? Ans: Global Blood Screening Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Blood Screening market? Ans: The important key players in the Global Blood Screening Market are – Abbott Laboratories, Grifols, Roche Diagnostics, Thermo Fisher Scientific, Inc., bioMérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers, Ortho Clinical Diagnostics, Inc., 5. What is the study period of this market? Ans: The Global Blood Screening Market is studied from 2022 to 2029.
Blood Screening Market1. INTRODUCTION 1.1 Report Description 1.1.1 Objectives of the Study 1.1.2 Market Scope 1.1.3 Years considered in the study 1.1.4 Currency 1.1.5 Stakeholders 1.2 Target Audience 1.3 Key Takeaways 2. RESEARCH METHODOLOGY 2.1 Research Methodology 2.2 Market Definition 2.3 Assumptions and Acronyms Used 2.4 Data Sources 2.4.1 Secondary 184.108.40.206 Paid 220.127.116.11 Unpaid 2.4.2 Primary 2.5 Analyst tools and models 3. EXECUTIVE SUMMARY 3.1 Blood Screening Market Overview 3.1.1 Blood Screening Market : By Technology 3.1.2 Blood Screening Market : By Product & Service 3.1.3 Blood Screening Market : By End User 3.1.4 Blood Screening Market : By Region 4. BLOOD SCREENING MARKET OUTLOOK 4.1 Blood Screening Market : Market Definition, Segmentation and Scope of Study 4.2 Blood Screening Market : Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Blood Screening Market : Competitive Analysis 4.3.1 Key Strategic Initiatives 4.3.2 Regional Presence 4.3.3 Product Overview 4.4 Blood Screening Market : Porter’s Analysis 4.5 Blood Screening Market : PESTEL Analysis 4.6 Blood Screening Market : Product Benchmark Analysis 4.7 Blood Screening Market : Company Market Share Analysis 4.8 Blood Screening Market : Key Findings 4.8.1 Blood Screening Market : Top Wining Strategies 4.8.2 Blood Screening Market : Top Investment Pockets 4.8.3 Blood Screening Market : Top Impacting Factors 5. BLOOD SCREENING MARKET, BY TECHNOLOGY 5.1 Blood Screening Market : Technology segment Market Share analysis 5.2 Blood Screening Market : Technology segment Market Size and Forecast 2021-2029 5.3 Blood Screening Market by Nucleic Acid Test (NAT) 5.4 Blood Screening Market by Enzyme-linked Immunosorbent Assay (ELISA) 5.5 Blood Screening Market by Rapid Tests 5.6 Blood Screening Market by Western Blot Assay 5.7 Blood Screening Market by Next-generation Sequencing (NGS) 5.8 Blood Screening Market Benchmarking By Technology 5.9 Blood Screening Market by Technology : Key Trends 5.10 Blood Screening Market by Technology : Key Developments 6. BLOOD SCREENING MARKET , BY PRODUCT & SERVICE 6.1 Blood Screening Market : Product & Service segment Market Share Analysis 6.2 Blood Screening Market : Product & Service segment Market Size and Forecast 2021-2029 6.3 Blood Screening Market by Reagents & Kits 6.4 Blood Screening Market by Enzymes and Polymerases 6.5 Blood Screening Market by Standards and Controls 6.6 Blood Screening Market by Probes and Primers 6.7 Blood Screening Market by Buffers, Nucleotides, and Solutions 6.8 Blood Screening Market by Labeling and Detection Reagents 6.9 Blood Screening Market by Immunosorbents 6.10 Blood Screening Market by Controls 6.11 Blood Screening Market by Conjugates 6.12 Blood Screening Market by Substrates 6.13 Blood Screening Market by Sample Diluents and Wash Solutions 6.14 Blood Screening Market by Instruments 6.15 Blood Screening Market by Software and Services 6.16 Blood Screening Market Benchmarking By Product & Service 6.17 Blood Screening Market by Product & Service: Key Trends 6.18 Blood Screening Market by Product & Service: Key Developments 7. BLOOD SCREENING MARKET, BY END USER 7.1 Blood Screening Market : End User segment Market Share analysis 7.2 Blood Screening Market : End User segment Market Size and Forecast 2021-2029 7.3 Blood Screening Market by Blood Banks 7.4 Blood Screening Market by Hospitals 7.5 Blood Screening Market Benchmarking By End User 7.6 Blood Screening Market by End User: Key Trends 7.7 Blood Screening Market by End User: Key Developments 8. BLOOD SCREENING MARKET , BY GEOGRAPHY 8.1 Blood Screening Market : Geography segment Market Share Analysis 8.2 Blood Screening Market : Geography segment Market Size and Forecast 2021-2029 8.3 North America 8.3.1 Overview 8.3.2 Blood Screening Market Size and Forecast, by Technology 2021-2029 8.3.3 Blood Screening Market Share Analysis , by Technology 2021-2029 8.3.4 Blood Screening Market Size and Forecast, by Product & Service 2021-2029 8.3.5 Blood Screening Market Share Analysis , by Product & Service 2021-2029 8.3.6 Blood Screening Market Size and Forecast, by End User 2021-2029 8.3.7 Blood Screening Market Share Analysis , by End User 2021-2029 8.4 Europe 8.4.1 Overview 8.4.2 Blood Screening Market Size and Forecast, by Technology 2021-2029 8.4.3 Blood Screening Market Share Analysis , by Technology 2021-2029 8.4.4 Blood Screening Market Size and Forecast, by Product & Service 2021-2029 8.4.5 Blood Screening Market Share Analysis , by Product & Service 2021-2029 8.4.6 Blood Screening Market Size and Forecast, by End User 2021-2029 8.4.7 Blood Screening Market Share Analysis , by End User 2021-2029 8.5 Asia Pacific 8.5.1 Overview 8.5.2 Blood Screening Market Size and Forecast, by Technology 2021-2029 8.5.3 Blood Screening Market Share Analysis , by Technology 2021-2029 8.5.4 Blood Screening Market Size and Forecast, by Product & Service 2021-2029 8.5.5 Blood Screening Market Share Analysis , by Product & Service 2021-2029 8.5.6 Blood Screening Market Size and Forecast, by End User 2021-2029 8.5.7 Blood Screening Market Share Analysis , by End User 2021-2029 8.6 Latin America, Middle East and Africa 8.6.1 Overview 8.6.2 Blood Screening Market Size and Forecast, by Technology 2021-2029 8.6.3 Blood Screening Market Share Analysis , by Technology 2021-2029 8.6.4 Blood Screening Market Size and Forecast, by Product & Service 2021-2029 8.6.5 Blood Screening Market Share Analysis , by Product & Service 2021-2029 8.6.6 Blood Screening Market Size and Forecast, by End User 2021-2029 8.6.7 Blood Screening Market Share Analysis , by End User 2021-2029 8.7 Blood Screening Market Benchmarking By Geography 8.8 Blood Screening Market by Geography : Key Trends 8.9 Blood Screening Market by Geography : Key Developments 9. COMPITITIVE LANDSCAPE 9.1 Blood Screening Market Share/ Positioning Analysis 9.2 Blood Screening Market: Key Innovators 9.3 Blood Screening Market : Company Profiles 9.3.1 Abbott Laboratories 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.2 Grifols 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.3 Roche Diagnostics 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.4 Thermo Fisher Scientific, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.5 bioMérieux 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.6 Bio-Rad Laboratories, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.7 Siemens Healthineers 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.8 Ortho Clinical Diagnostics, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.9 Becton, Dickinson and Company 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.10 Beckman Coulter, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.11 Becton Dickinson and Company 9.3.12 Grifols 9.3.13 Danaher Corporation (Beckman Coulter) 9.3.14 F. Hoffmann-La Roche Ltd. 9.3.15 Enzo Biochem Inc. 9.3.16 Meridian Bioscience, Inc. 9.3.17 BD 9.3.18 Cepheid 9.3.19 Immucor, Inc. 9.3.20 Hologic Inc 10. CONSOLIDATION 10.1 Blood Screening Market: Mergers and Acquisitions 10.1.1 Overview 10.1.2 Blood Screening Market : Key Drivers – By Region 10.1.3 Blood Screening Market : M&A Breakdown 10.1.3.1 Technology Based 10.1.3.2 Product & Service Based 10.1.3.3 End user Based 10.1.3.4 Niche Based 10.1.3.5 Region Based 10.1.3.6 Asset & Non-Asset Based 10.1.3.7 Venture Capitalist Based 10.2 Fragmentation of Blood Screening Market 10.3 Blood Screening Market : Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 10.4 Blood Screening Market - New/Emerging Models of Partnerships : Key Examples 10.5 Blood Screening Market : New/Emerging Business Models : Key Examples 10.6 Blood Screening Market - Changing Investment Paradigm : Focused areas by Key Players 10.7 Blood Screening Market - Patent Analysis 11. Blood Screening Market : LIST OF TABLES 12. Blood Screening Market : LIST OF FIGURES